Van Tuyl Christopher insider trades
Van Tuyl Christopher has filed 11 Form 4s with the SEC that we hold, all for Immunovant, Inc. (IMVT), as Chief Legal Officer. Across all of them we count 0 purchases worth $0 and 11 sales worth $1.5M reported on Form 4. In the last 12 months: 0 purchases ($0) and 11 sales ($1.5M). The largest single trade was a sale of 14,982 shares of Immunovant, Inc. worth $572.2K, dated 2026-06-26. Of 2 sales filed since we began reading the 10b5-1 checkbox, 0 (0%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2024-12-18 and the latest 2026-10-09.
Immunovant, Inc. (IMVT)
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2025-12-18 | S, sale reported on Form 4 | 2,284 | $62.5K | 2025-12-19 | SEC |
| 2025-12-18 | S, sale reported on Form 4 | 8,529 | $228.4K | 2025-12-19 | SEC |
| 2026-03-18 | S, sale reported on Form 4 | 2,877 | $71.8K | 2026-03-20 | SEC |
| 2026-04-08 | S, sale reported on Form 4 | 5,165 | $128.2K | 2026-04-10 | SEC |
| 2026-06-18 | S, sale reported on Form 4 | 2,634 | $93.2K | 2026-06-22 | SEC |
| 2026-06-26 | S, sale reported on Form 4 | 2,842 | $110.7K | 2026-06-26 | SEC |
| 2026-06-26 | S, sale reported on Form 4 | 14,982 | $572.2K | 2026-06-26 | SEC |
| 2026-07-08 | S, sale reported on Form 4 | 1,143 | $45.2K | 2026-07-10 | SEC |
| 2026-07-08 | S, sale reported on Form 4 | 63 | $2.5K | 2026-07-10 | SEC |
| 2026-09-23 | S, sale reported on Form 4 | 2,846 | $103.5K | 2026-09-25 | SEC |
| 2026-10-07 | S, sale reported on Form 4 | 1,327 | $42.5K | 2026-10-09 | SEC |
Counted from the Form 4 filings this reporting owner (SEC CIK 1779707) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
